Computational cancer neoantigen prediction: current status and recent advances

Area of Science:

• Oncology
• Immunology
• Bioinformatics

Background:

• Immunotherapy has revolutionized cancer treatment by harnessing the immune system.
• Antitumor immune responses rely on recognizing tumor-specific antigens called neoantigens.
• Neoantigens are key targets for effective cancer immunotherapy and immune checkpoint blockade.

Purpose of the Study:

• To systematically review recent advances in computational neoantigen prediction.
• To discuss current challenges and emerging methods in neoantigen identification.

Main Methods:

• Review of computational approaches for predicting tumor-specific peptides.
• Analysis of methods quantifying neoantigen binding to human leukocyte antigen (HLA) molecules.
• Systematic summary of recent developments in the field.

Main Results:

• Computational neoantigen prediction is essential for personalized cancer immunotherapy.
• Various computational tools have been developed to identify and prioritize neoantigens.
• The accuracy of neoantigen prediction is critical for T-cell recognition and therapeutic response.

Conclusions:

• Accurate neoantigen identification is fundamental for advancing immuno-oncology.
• Ongoing research focuses on refining computational methods to overcome prediction challenges.
• Novel approaches are being developed to enhance the prediction of immunogenic neoantigens.